News from Cytotheryx

Cytocine™ Cryopreserved Primary Porcine Hepatocytes offer a valuable alternative to human hepatocytes for preclinical research applications. With high viability, plateability, metabolic functionality, and scalability, Cytocine™ hepatocytes provide a reliable and cost-effective solution for researchers who need a consistent supply of cells for their experiments. Dive into our latest White Paper to learn more about this new source of high-quality liver cells to support biomedical research.

ROCHESTER, Minnesota, Oct. 11, 2024 – Cytotheryx, Inc., a privately held company focused on the development of a consistent, high-quality source of human hepatocytes (liver

We are thrilled to share that the Rochester City Council has approved sponsoring Cytotheryx for applications to the Minnesota Department of Employment and Economic Development for the Minnesota Investment Fund and the Minnesota Job Creation Fund. We are hoping to secure a total of $870,000 in funding to support expansion in Rochester to further our mission.